AngioDynamics, Inc.
General ticker "ANGO" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $451.9M (TTM average)
AngioDynamics, Inc. follows the US Stock Market performance with the rate: 41.3%.
Estimated limits based on current volatility of 4.7%: low 13.29$, high 14.53$
Factors to consider:
- Total employees count: 675 (-9.8%) as of 2025
- US accounted for 29.7% of revenue in the fiscal year ended 2024-05-31
- Top business risk factors: Market competition, Technological changes, Product acceptance, Regulatory and compliance, Acquisition/divestiture risks
- Current price 47.2% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-05-31 to 2027-05-31
- 2025-05-31 to 2026-05-31 estimated range: [4.92$, 10.72$]
- 2026-05-31 to 2027-05-31 estimated range: [4.07$, 9.17$]
Financial Metrics affecting the ANGO estimates:
- Positive: with PPE of -65.0 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Shareholder equity ratio, % of 65.31 > 64.23
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -9.70 < Industry operating profit margin (median), % of -6.87
Short-term ANGO quotes
Long-term ANGO plot with estimates
Financial data
| YTD | 2023-05-31 | 2024-05-31 | 2025-05-31 |
|---|---|---|---|
| Operating Revenue | $338.75MM | $303.91MM | $292.50MM |
| Operating Expenses | $389.93MM | $496.35MM | $332.45MM |
| Operating Income | $-51.18MM | $-192.44MM | $-39.95MM |
| Non-Operating Income | $-3.26MM | $0.80MM | $5.92MM |
| Interest Expense | $2.70MM | $0.00MM | $0.00MM |
| R&D Expense | $29.88MM | $31.51MM | $26.22MM |
| Income(Loss) | $-54.44MM | $-191.64MM | $-34.03MM |
| Taxes | $-2.00MM | $-7.29MM | $-0.04MM |
| Net Income(Loss)* | $-52.44MM | $-184.35MM | $-33.99MM |
| Stockholders Equity | $378.30MM | $205.59MM | $182.97MM |
| Inventory | $55.33MM | $60.62MM | $62.01MM |
| Assets | $532.64MM | $317.67MM | $280.14MM |
| Operating Cash Flow | $0.08MM | $-28.16MM | $-10.13MM |
| Capital expenditure | $4.35MM | $5.77MM | $4.46MM |
| Investing Cash Flow | $-9.75MM | $123.72MM | $-10.18MM |
| Financing Cash Flow | $25.42MM | $-64.25MM | $-0.26MM |
| Earnings Per Share** | $-1.33 | $-4.59 | $-0.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.